Markets:

Overview

News

Currencies

International

Treasuries

Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

3.235 +0.005 (+0.15%)

Streaming Delayed Price Updated: 10:33 AM EST, Dec 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gossamer Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 16, 2023

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 16, 2023

Via Benzinga

Where Gossamer Bio Stands With Analysts ↗

March 01, 2023

Via Benzinga

Barclays Downgrades Gossamer Bio: Here's What You Need To Know ↗

December 07, 2022

Via Benzinga

What 9 Analyst Ratings Have To Say About Gossamer Bio ↗

December 07, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 13, 2023

Via Benzinga

Analyst Downgrades Gossamer Bio As Merck's Sotatercept Might Overshadow Seralutinib's Success ↗

March 07, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 ↗

March 07, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023 ↗

March 01, 2023

Via Benzinga

7 Top Short-Squeeze Candidates to Watch in February ↗

February 01, 2023

For those that want to zig while others zag, these heavily targeted stocks represent the top short-squeeze candidates to watch this month.

Via InvestorPlace

Looking Into Gossamer Bio's Recent Short Interest ↗

January 03, 2023

Gossamer Bio's (NASDAQ:GOSS) short percent of float has fallen 32.89% since its last report. The company recently reported that it has 14.41 million shares sold short, which is 17.59% of all regular...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 22, 2022

Via Benzinga

Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday ↗

December 08, 2022

Via Benzinga

ConocoPhillips To Rally Over 30%? Here Are 10 Other Price Target Changes For Wednesday ↗

December 07, 2022

Barclays raised ConocoPhillips (NYSE: COP) price target from $135 to $151. Barclays analyst Jeanine Wai maintained an Overweight rating on the stock. ConocoPhillips shares fell 3.2% to close at $115.61...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 23, 2022

OnFriday, 143 stocks hit new 52-week lows.

Via Benzinga

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

December 19, 2022

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Via Benzinga

Dow Dips Over 500 Points; Nasdaq Down 2.5% ↗

December 06, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 2.5% on Tuesday.

Via Benzinga

Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session ↗

December 07, 2022

Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...

Via Benzinga

Analyst Turns Bullish On Aerovate As Competitor Data Reinforce Lead Program Thesis ↗

December 06, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 06, 2022

Via Benzinga

Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session ↗

December 06, 2022

Gainers Summit Therapeutics Inc. (NASDAQ: SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific...

Via Benzinga

Souring Sentiment On Wall Street Sends Dow Down Triple Digits ↗

December 06, 2022

Doubts over the Fed's next move are being compounded with renewed recession anxieties, and this sour sentiment is weighing on markets this afternoon.

Via Talk Markets

S&P 500 Down Over 1%; Crude Oil Falls Sharply ↗

December 06, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 250 points on Tuesday.

Via Benzinga

President Biden Is Bringing Taiwan Semi (TSM) Stock a HUGE Catalyst ↗

December 06, 2022

Taiwan Semiconductor (TSM) stock is on the move Tuesday as investors prepare for President Joe Biden to visit the company's Arizona plant.

Via InvestorPlace

Meta Platforms, Herbalife And Some Other Big Stocks Moving Lower On Tuesday ↗

December 06, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Is Gossamer Bio (GOSS) Stock Down Over 70% Today? ↗

December 06, 2022

GOSS stock is plunging over 70%. The company's hypertension drug reportedly failed to perform better than a competing treatment.

Via InvestorPlace

Dow Drops 100 Points; US Trade Deficit Widens In October ↗

December 06, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Tuesday.

Via Benzinga

Gossamer Bio Shares Plummet As Hypertension Trial Fall Short Of Expectation ↗

December 06, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 06, 2022

Via Benzinga

Gossamer Bio Announces Seralutinib Meets Primary Endpoint in Phase 2 TORREY Study in PAH

December 06, 2022

From Gossamer Bio, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.